Childhood membranous nephropathy, circulating antibodies to the 58-kD TIN antigen, and anti-tubular basement membrane nephritis: An 11-year follow-up by Iványi, Béla et al.
Childhood Membranous Nephropathy, Circulating Antibodies
to the 58-kD TIN Antigen, and Anti-Tubular Basement Membrane
Nephritis: An 11-Year Follow-Up
Be´la Iva´nyi, MD, PhD, Ibolya Haszon, MD, Emo¨ke Endreffy, MD, PhD, Pa¨l Szenohradszky, MD,
Ildiko´ B. Petri, MD, PhD, Tibor Kalma´r, MD, Ralph J. Butkowski, MD, PhD,
Aristidis S. Charonis, MD, PhD, and Sa´ndor Tu´ri, MD, PhD
c Childhood membranous nephropathy (MNP) with anti–tubular basement membrane (anti-TBM) nephritis is a rare
disorder that may have extrarenal manifestations. This article describes a new case to be added to the 10 previously
reported. A renal biopsy specimen from a 1-year-old white boy with nephrotic syndrome, microhematuria, and
hypertension showed MNP (granular global IgG, IgA and C3, and segmental IgM and C1q) associated with
hypercellularity and granular deposits of IgM and C1q in the mesangium, arteriolar IgA, and linear TBM IgG, IgA, and
C3. A biopsy at age 4 years showed MNP (IgG and C3) and linear IgG and C3 along the TBM. Six months later,
temporary glucosuria suggested a mild tubular dysfunction. Biopsy at age 8 years showed sclerosing MNP (IgG and
C3), linear TBM IgG and C3, and chronic active tubulointerstitial nephritis (TIN). Indirect immunofluorescence
showed circulating anti-TBM antibodies, and the enzyme-linked immunosorbent assay (ELISA) approach verified
strong reactivity with the 58-kd TIN antigen. Despite trials with steroids, chlorambucil, azathioprine, and cyclospo-
rine, end-stage renal disease developed by the age of 9 years. At age 10 years, the patient received a cadaveric
kidney transplant. With the patient now aged 12 years, the graft is still functioning well, without any clinical evidence
of disease recurrence. Neurological, ocular, and abdominal symptoms, including nonbacterial diarrhea, were
observed during the follow-up period. The pathophysiology of these extrarenal symptoms remains unclear.
Serotyping and genotyping of HLA antigens (A2, A10, B12, B41, DR5 [1101, 1103-4, 1106 or 1108-1113], DR6 [1303,
1312, or 1413], DRB3 [*0101 and 0201-2 or 0301], DQA1 [*0501 homozygous], and DQB1 [*0301 homozygous]) did not
indicate any HLA association similar to those decribed previously in childhood MNP with anti-TBM nephritis
(HLA-B7 in four patients, HLA-DR8 in two patients). The presented case is the fifth in the literature that displays
reactivity with the 58-kd TIN antigen, and for which data on HLA antigens are reported.
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MEMBRANOUS nephropathy (MNP) is in-frequent in children, with an incidence
below 5%.1,2 Childhood MNP occasionally may
be associated with linear3-9 or granular10,11 depos-
its of immunoglobulin G (IgG) and C3 along the
tubular basement membrane (TBM). The linear
immunodeposits indicate the presence of anti-
TBM nephritis. Primary anti-TBM nephritis is
characterized by linear TBM immunodeposits,
interstitial mononuclear infiltrates, tubulitis, tubu-
lar damage/atrophy, interstitial fibrosis, the ultra-
structural absence of electron-dense deposits in
the TBM, circulating anti-TBM antibodies, a
tubular dysfunction, and progressive azote-
mia.12-14 Anti-TBM antibodies have been occa-
sionally documented at times in a variety of
renal diseases,15 such as drug-induced tubuloint-
erstitial nephritis (TIN),16 anti–glomerular base-
ment membrane nephritis,17 renal allografts,18
poststreptococcal glomerulonephritis,19 lupus ne-
phritis,20 and MNP of children.3-9 The latter asso-
ciation is the subject of the current communica-
tion.
CASE REPORT
A 10-month-old white boy was admitted with the ne-
phrotic syndrome (proteinuria: 3.9 g/day, serum albumin
level: 2.1 g/dL, edema), microhematuria, and hypertension
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(130/80 mm Hg). Serum studies showed normal electro-
lytes, creatinine, and the third complement component (C3).
Glucosuria and aminoaciduria were not detected. In re-
sponse to a daily prednisone regimen of 60 mg/m2 body
surface area (BSA), the proteinuria decreased to 0.2 g/24 h,
the hematuria disappeared, and the blood pressure normal-
ized. Within 2 months, however, the patient became steroid
dependent, and a percutaneous kidney biopsy was per-
formed (March 1987). Results of tests for lupus erythemato-
sus cell and anti-DNA antibody were negative. The treat-
ment was continued with prednisone (1 mg/kg/d) and
indomethacine (1 mg/kg/d), given alternately. At the age of 3
years, the patient had epileptic seizures, which were treated
with carbamazepine. At the age of 4 years, the proteinuria
became steroid resistant, and the nephrotic syndrome was
manifested again (proteinuria: 6 g/d). Additional findings
were microhematuria, a reduced urine concentrating capac-
ity, hypertension (140/90 mm Hg), and normal serum creati-
nine and glucose levels. Glucosuria and aminoaciduria were
still not observed. A new renal biopsy was performed (May
1990). Subsequently, a 6-week period of chlorambucil (0.2
mg/kg/d) and prednisone (40 mg/m2 BSA every other day)
was initiated, but without success.
Methylprednisolone pulse therapy (3 3 500 mg) was then
tried, followed by a 6-week azathioprine (1 mg/kg/d) treat-
ment. The proteinuria fluctuated between 0.5 and 6 g/24 h;
the hematuria persisted. The hypertension was treated with
an angiotensin-converting enzyme inhibitor, a Ca-channel
blocker, and diuretics, and the hypercholesterinemia with
bezafibrate. At the age of 4.5 years, glucosuria was observed
(250 mg/L to 1.3 g/L), although the blood glucose levels
were in the normal range. The glucosuria later disappeared.
At the age of 5 years, the child suffered from frequent
headaches, bulbar pain, visual disturbances associated with
nausea, vomiting, tremor, a broad-based gait, abdominal
pain, and nonbacterial diarrhea reminiscent of a lactase
deficiency. The results of cranial radiograph, computed
tomography scan, and ophthalmological investigations were
negative. Electroencephalogram showed only a mild irregu-
lar cerebral activity. The explanation of these unusual symp-
toms remains unclear. The ocular and abdominal complaints
slowly ceased. Because the laboratory tests constantly veri-
fied the nephrotic syndrome and azotemia appeared (serum
creatinine 1.4 mg/dL), a low-protein diet and cyclosporine A
(4 mg/kg/d) were initiated. The administration of cyclo-
sporine was stopped 2 months later because the neurological
symptoms had worsened; this was attributed to the side
effects of the drug. At the age of 8 years, the serum
creatinine was 2 mg/dL, and the creatinine clearance was
reduced to 30 mL/min/m2. Despite forced antihypertensive
therapy, the patient had an elevated blood pressure (150/100
mm Hg). A further renal biopsy was performed (June 1994),
and the serum of the patient was tested toward circulating
anti-TBM antibodies. At the age of 9 years, chronic hemodi-
alysis was started, and after 13 months of bicarbonate
hemodialysis, the patient underwent a successful cadaveric
kidney transplantation. The native kidneys were not re-
moved. The child is now 12 years of age, and his allograft is
functioning well, without clinical evidence of the recurrence
of the disease. He is receiving cyclosporine, azathioprine,
and steroid. The most recent parameters include the follow-
ing: proteinuria below 0.5 g/day, no glucosuria, serum creati-
nine, electrolyte and acid-base levels normal, and blood
pressure normal (100/70 mm Hg).
Morphological Studies
The renal biopsy specimens were processed for light
microscopy, direct immunofluorescence (IF) (IgG, IgA, IgM,
fibrinogen, C3 and C1q), and electron microscopy with
standard methods. Indirect IF was performed on normal
human kidney tissue to detect circulating anti-TBM antibod-
ies.
Immunochemical Analysis
The serum obtained at the time of the third biopsy (1994)
was used to test the reactivity of antibodies toward the 58-kd
TIN antigen by enzyme-linked immunosorbent assay
(ELISA), and other components of the TBM by Western
blotting, as described.5
HLA Serotyping and Genotyping
Serologic HLA class I and class II typing was performed
before renal transplantation, with standard methods. The
genotyping of HLA-DRB, DQA1, and DQB1 alleles was
performed in total cellular DNA isolates from peripheral
blood leukocytes. For HLA-DRB analysis, the Amplicor kit
(Hoffman-La Roche, Basel, Switzerland) was applied. The
DQA1 typing was performed with a modified PCR-RFLP
procedure,21 and the DQB1 typing with the INNO-LiPA/
DQB1 kit.
RESULTS
The renal biopsy findings are summarized in
Table 1. MNP and linear staining with IgG along
the TBMs are shown in Figs 1 and 2, respec-
tively.
Indirect IF showed circulating anti-TBM anti-
bodies at a concentration of 1:16 (Fig 3). Circu-
lating anti-TBM antibodies were tested 1 and 2
years after transplantation, with negative results.
The ELISA approach disclosed a high reactivity
of the 58-kd TIN antigen at dilutions of 1:250,
1:50, and 1:10. Even at the 250-fold dilution, the
reactivity was strong at 1 minute. In the Western
blot experiment, no reactivity was detected.
The serotyping of HLA antigens showed A2,
A10, B12, B41, DR5, and DR6 antigens. The
genotyping verified DR5 (1101, 1103-4, 1106 or
1108-1113), DR6 (1303, 1312, or 1413), DRB3
(*0101 and 0201-2 or 0301), DQA1 (*0501
homozygous), and DQB1 (*0301 homozygous)
alleles.
DISCUSSION
With the addition of the presented case (pa-
tient 11) to the previously described ones, 11
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cases of childhood MNP with anti-TBM nephri-
tis have been published in the English literature
(Table 2). The clinical features include a male
preponderance, onset in early childhood (median
age at renal biopsy, 3 years), nephrotic-range
proteinuria, microhematuria, complete or incom-
plete Fanconi syndrome, circulating antibodies
against the TBM, and renal insufficiency. Two
patients responded to steroid treatment. Progres-
sion to end-stage renal disease was reported in
six patients. Four patients received a renal trans-
plant. The anti-TBM nephritis recurred in patient
5. Graft loss, however, was due to chronic rejec-
tion 3.5 years after transplantation.5
During the past few years, several autoanti-
gens have been isolated from collagenase digests
of the human TBM.22-24 Among these, the 58-kd
TIN antigen is a glycoprotein macromolecule25,26
that promotes epithelial cell adhesion.27,28 Immu-
nofluorescence found that the TIN antigen had
the highest expression in the BM of the proximal
tubules. The expression was lower in the BM of
the Bowman’s capsules and distal tubules and
Table 1. Renal Biopsy Findings
Year Light Microscopy Direct Immunoflurescence Electron Microscopy
1987 Glomerular tufts Segmental thickening with
spikes
Granular IgG, IgA and C3; seg-
mental IgM and C3
MNP, stage II-III
Mesangium Foc-segm proliferation and
increase of matrix
Granular IgM and C1q Electron-dense deposits
TIS Normal Linear IgG, IgA, and C3 along
60% of the TBMs
No deposits
Vessels Normal One arteriole: IgA Arterioles: no change
1990 Glomerular tufts Diffusely thickened, spikes Granular IgG and C3 Relapsing MNP, stage II-III
Mesangium No change No deposits No deposits
TIS Normal Linear IgG and C3 along 70% of
the TBMs
No deposits
Vessels No change No change Not available
1994 Glomeruli Mainly sclerotic, open tufts:
thickened, spikes
Granular IgG and C3 in patent
glomeruli
Sclerotic
TIS ISF, TA, focal mononuclear infil-
trates, 21 tubulitis
Linear IgG and C3 along the
TBM
No deposits
Vessels Arterioles with 2-3 smooth
muscle layers
No change Not available
NOTE. In 1987 and 1990, the tubular immunostaining was interpreted as pseudolinear. In 1994, the diagnosis of sclerosing
MNP associated with chronic active anti-TBM nephritis was set up.
Abbreviations: MNP, membranous nephropathy; Foc-segm, focal and segmental; ISF, interstitial fibrosis; TA, tubular
atrophy; 21, 7 lymphocytes/profile; TBM, tubular basement membrane; TIS, tubulointerstitium.
Fig 1. Membranous nephropathy: Granular depos-
its of IgG along glomerular capillaries (original magni-
fication 3160).
Fig 2. Linear immunostaining of IgG along tubular
basement membranes (original magnification 3160).
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was absent from the glomerular BM and the
mesangial matrix. In extrarenal tissues, the TIN
antigen was localized in the small intestinal,
corneal, and epidermal BMs.29 In our patient, the
ELISA approach showed that the patient’s anti-
bodies strongly recognize the 58-kd TIN antigen.
The results from the immunoblotting approach
were negative, and therefore nothing could be
said as to whether the serum reacted with other
TBM components besides the TIN antigen. The
negativity may be because the autoantibodies are
unable to recognize the 58-kd molecule in the
conformation present after electrophoresis and
blotting. In patients 3, 4, and 5, Western blotting
showed a light stain for a 175-kd TBM protein,
which could be the 58-kd form bound to another
protein, or a trimer of the 58-kd form.5 Because
the anti-TBM antibodies strongly reacted with
the 58-kd TIN antigen in all five patients tested
so far (Table 2), the 58-kd form seems to be the
primary target antigen in anti-TBM nephritis.
The first biopsy showed the coexistence of
MNP, hypercellularity and granular immunode-
posits of the mesangium, and linear immunostain-
ing along the TBM. Mesangial-immunocomplex
nephritis-like changes have not been observed in
cases of childhood MNP with anti-TBM nephri-
tis. The second biopsy, however, did not show
the mesangial alterations seen in the first biopsy,
either because of the intrinsic nature of the dis-
ease, or as a consequence of the therapy. The
clinical picture in our patient was predominated
by the nephrotic syndrome and hypertension.
Although TBM immunodeposits were already
present at the times of the first and second
biopsies, the clinical and morphological signs of
anti-TBM nephritis were not manifested in the
first 3 years of the disease. Later, temporary
glucosuria was observed, indicating a mild tubu-
lar dysfunction, and the third biopsy, 7 years
after the onset, showed chronic active TIN. Simi-
larly to what was found in our patient, in patients
2, 6, and 8, the immunodeposits along the TBM
were not associated with detectable defects in the
tubular function at the time of the biopsy, and in
patients 6 and 8, the TBM immunodeposits were
not accompanied by light microscopic evidence
of TIN. The first biopsy in patients 7 and 10
verified the MNP but did not show any light
microscopic or immunomorphological change in
the tubulointerstitium, and the renal symptoms at
the time of the biopsy did not indicate tubuloint-
erstitial disease. These data strongly suggest that
in childhood MNP with anti-TBM nephritis, the
glomerular disease is the primary lesion, and the
formation of anti-TBM antibodies, their fixation
to the TBM, and the development of TIN and
tubular dysfunction are secondary phenomena.
The manner in which MNP elicits the formation
of anti-TBM antibodies is unclear. It may be
interesting to mention that also in primary MNP
associated with formation of anti-glomerular BM
antibody, MNP—as characterized by long-stand-
ing nephrotic syndrome and granular immune
deposits on the epithelial side of the glomerular
BM—seems to precede the anti-glomerular BM
response and the development of rapidly progres-
sive, crescentic glomerulonephritis.30,31 In our
patient, the end-stage kidneys were not removed
at transplantation. Because the MNP or anti-
TBM nephritis did not recur after transplanta-
tion, the autoimmune process seemed to be
‘‘burned out’’during the months of chronic hemo-
dialysis.
Childhood MNP may exhibit extrarenal organ
involvement, such as the intestinal villous atro-
phy in patient 8, or the lung hemorrhage in
patients 1 and 9. In patient 8, high titers of
circulating autoantibodies directed against the
cytoplasm of the intestinal epithelial cells were
verified. Direct IF, however, did not show immu-
noglobulin or complement deposition in the intes-
tinal epithelium, which makes the role of the
anti-intestinal epithelial cell antibody in produc-
ing intestinal injury uncertain.7 The pathomecha-
nism of the lung hemorrhage in patient 9 was
unresolved. The nature of the extrarenal symp-
Fig 3. Normal human renal cortex incubated with
the patient’s serum (1:16) and stained with rabbit anti-
human IgG: Linear tubular basement membrane depo-
sition of IgG can be seen (original magnification 3160).
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Table 2. Features of Childhood Membranous Nephropathy With Anti-TBM Nephritis
Patient
Biopsy
(age in
years)
Renal
Symptoms TIN
TBM
IgG
Circulating
Anti-TBM ABs
Renal
Outcome
Extrarenal
Involvement Reference
1, Boy 3.8 Proteinuria, Fan-
coni syn-
drome, azo-
temia
Yes Linear and
granular
Positive ESRD at 5 y Lung infiltrates,
anti-alveolar
BM Abs
3
2, Boy 7 NS; incomplete
Fanconi syn-
drome 1 year
later
Yes Linear Positive Not reported Earlier: gluten-
sensitive
celiakia
4
3, Boy 3.7 NS, microhema-
turia, glucos-
uria
Yes Linear Positive* ESRD at 13 y;
Tx
Not reported 5
4, Boy 2.2 NS, microhema-
turia, glucos-
uria
Yes Linear Positive* Not reported 5
2.5 NS, azotemia Yes Linear Positive ESRD; Tx
5, Boy 4.5 NS, microhema-
turia, Fanconi
syndrome
Prob Not reported Positive after Tx* ESRD at 11.5 y;
Tx†
Not reported 5
6, Boy 1.7 NS, microhema-
turia; no
tubular
defects
No Linear Negative Not reported 6
6 Proteinuria, Fan-
coni syn-
drome, azo-
temia
Yes Linear Negative Renal insuffi-
ciency
7, Girl 10 NS, microhema-
turia; glucos-
uria later
No No deposit Negative Not reported 6
14 Proteinuria,
tubular
defects, azo-
temia
Yes Linear Negative Renal insuffi-
ciency
8, Boy 3 NS, microhema-
turia, no
tubular
defects
No Linear Positive Responded to
steroid
Malabsorption,
villous atrophy
7
9, Boy 2.2 Proteinuria, azo-
temia; no
tubular
defects
No No deposit Not tested Anemia, dys-
pnea
8
3 NS, Fanconi
syndrome,
azotemia
Yes Linear Positive ESRD at 8 y Alveolar hemor-
rhage, no anti-
alveolar BM
Abs
10, Boy 0.9 NS, microhema-
turia; no
tubular
defects
No No deposit Not tested 9
2 NS, microhema-
turia, Fanconi
syndrome
Yes Linear Positive* Responded to
steroid
Not reported
11, Boy 1
4
8
NS, microhema-
turia, no
tubular
defects
NS, microhema-
turia; glucos-
uria later
NS, azotemia
No
No
Yes
Linear
Linear
Linear
Not tested
Not tested
Positive* ESRD at 9 y; Tx
At 3 y: epilepsy,
at 5 y: ocular,
neurological,
and
abdominal
symptoms
Presented
case
Abbreviations: TBM, tubular basement membrane; Ab, antibody; NS, nephrotic-range proteinuria; TIN, tubulointerstitial
nephritis by light microscopy; ESRD, end-stage renal disease; Tx, kidney transplantation; prob, probable.
*Reactivity with the 58-kd TIN antigen.
†The anti-TBM nephritis recurred in the graft.
toms in our patient also remained unexplored.
Conceivably, the abdominal and ocular com-
plaints could stem from a mild, temporary im-
mune injury to the small bowel and cornea, as
the basement membranes of these tissues also
contain the TIN antigen. The neurological symp-
toms might be associated in part with the im-
mune injury to the choroid plexus and the dis-
turbed production of cerebrospinal fluid.32
Because our patient has been on cyclosporine
since renal transplantation, and the drug has not
affected his neurological status adversely, the
worsening of the neurological symptoms at age 7
was unlikely to have been attributable to a side
effect of cyclosporine, as thought originally.
The HLA status has so far been examined in
patients 3, 4, 5, and 10. All carried the B7
antigen, and patients 3 and 4 were also positive
for the DR8 antigen, suggesting that childhood
MNP with anti-TBM nephritis may be HLA-
linked, and the B7 or DR8 antigens provide
disease susceptibility. In healthy Hungarian indi-
viduals, the DQA1 *0501 and DQB1 *0301
alleles predominate,33 and these alleles in our
patient therefore belong to the normal profile. In
patients with MNP from England, Germany, and
France, the DR3 antigen has been found to be
frequent, often in association with the A1 and B8
antigens.34-37 In Hungarian patients with MNP,
only the A1 and A3 antigens, but not the B8,
DR2, or DR3 antigens, have been shown to have
an increased incidence.38 In conclusion, the HLA
status of our patient differed from any associa-
tion with HLA-antigens previously reported in
childhood MNP with anti-TBM nephritis or pri-
mary MNP in whites.
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